Inogen Inc
Medical device company · Beverly, Massachusetts, United States · Nasdaq: INGN
Inogen Inc is a medical device company headquartered in Beverly, Massachusetts, United States. Its shares trade on Nasdaq under the ticker INGN. The US FDA lists 2 medical device sites registered to the company, with devices in anesthesiology. It has reported private securities offerings to the US SEC, most recently $9.6 million sold in a notice filed in 2010.
Inogen at a glance
What does Inogen do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $9.6 million sold (2010).
Where is Inogen located?
Headquarters: Beverly, Massachusetts, United States
- Goleta, CaliforniaInogen, Inc. · FDA device site
- Plano, TexasInogen, Inc · FDA device site
Frequently asked questions about Inogen
Where is Inogen headquartered?
Inogen Inc is headquartered in Beverly, Massachusetts, United States.
What does Inogen do?
Inogen Inc is a medical device company. Its FDA-listed medical devices fall under anesthesiology. Its SEC industry classification is Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Is Inogen a public company?
Yes. Inogen Inc trades on Nasdaq under the ticker INGN.
How many FDA-registered sites does Inogen have?
The US FDA lists 2 registered sites for Inogen Inc.
Similar companies
- Spinefrontier IncBeverly, Massachusetts, United States
- LexaGene Holdings Inc.Beverly, Massachusetts, United States
- LeviSense Medical, Inc.Beverly, Massachusetts, United States
- Microline Surgical, Inc.Beverly, Massachusetts, United States
- Hamilton Thorne Ltd.Beverly, Massachusetts, United States
- GLAUKOS CorpAliso Viejo, California, United States
- Mobia Medical, Inc.Austin, Texas, United States
- Pulse Biosciences, Inc.Hayward, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences